Researchers call for an updated pain scale

Care providers underestimate pain during pediatric burn dressing change

Columbus, Ohio, USA (September 1, 2016) – Dressing changes have been identified as one of the major contributors to perceived pain during burn care, and so it is important that pain be assessed accurately. But a new study from the Center for Pediatric Trauma Research at Nationwide Children’s Hospital suggests that pediatric burn pain assessment can vary not only based on patient pain intensity, but also nurse clinical experience.

A measurement tool called the Face, Legs, Activity, Cry, Consolability Scale (FLACC) is widely used by nurses to rate pain in pediatric patients. It can be applied to pediatric patients of all ages, including the very young, so it provides a standard assessment for all patients in our pediatric burn center. This study found that nurses tended to underrate both mild and severe procedural pain. Nurses who had less nursing experience demonstrated significantly higher accuracy than those with more experience.

Jonathan Groner MD is the study’s senior author, medical director of the Center for Pediatric Trauma Research and affiliate faculty of the Center for Injury Research and Policy at Nationwide Children’s Hospital stated, "This is concerning because it demonstrates that on a well-established burn unit that specializes in caring for pediatric patients, nurses may too often underrate children’s procedural pain for both mild and severe pain." Dr. Jiabin Shen, the study’s lead author also noted concern that "new" burn nurses (less than 5 years nursing experience) appeared to be more accurate in FLACC rating than more experienced nurses.

This study, available today online and in the September issue of Burns, is the first study to systematically examine FLACC rating accuracy among care providers. Developed in 1997, the FLACC scale was originally designed to measure post-operative pain in pediatric populations. The FLACC utilizes an easy-to-understand 0-10 metric and exerts a relatively low burden on medical staff. It has previously demonstrated a high level of inter-rater reliability and concurrent validity with other existing scales. But much of the previous research was not in clinical settings.

###

To learn more or for related injury prevention materials, visit The Center for Injury Research and Policy (CIRP) of The Research Institute at Nationwide Children’s Hospital, http://www.injurycenter.org and the Center for Pediatric Trauma Research, http://www.nationwidechildrens.org/center-pediatric-trauma-research

The Center for Injury Research and Policy (CIRP) of The Research Institute at Nationwide Children’s Hospital works globally to reduce injury-related pediatric death and disabilities. With innovative research at its core, CIRP works to continually improve the scientific understanding of the epidemiology, biomechanics, prevention, acute treatment and rehabilitation of injuries. CIRP serves as a pioneer by translating cutting edge injury research into education, policy, and advances in clinical care. For related injury prevention materials or to learn more about CIRP, visit http://www.injurycenter.org

The Center for Pediatric Trauma Research (CPTR) at Nationwide Children’s Hospital conducts research to support global efforts in achieving the best outcomes for pediatric trauma patients. Using a multidisciplinary approach, CPTR researchers lead innovative projects to assess pre-hospital emergency medical service, acute medical and surgical management, rehabilitation, and family and community services that impact the short and long-term outcomes of injured patients. CPTR serves as a leader and a partner to translate cutting edge research findings to help patients, families, policy makers, and clinicians make informed decisions. http://www.nationwidechildrens.org/center-pediatric-trauma-Research


Nationwide Children’s Hospital , 01.09.2016 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…